https://www.zacks.com/stock/news/2232493/why-northrop-grumman-noc-is-a-top-momentum-stock-for-the-long-term?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_momentum_score-2232493
Feb 27, 2024 - The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
zc:-591357556517492985
0
https://www.zacks.com/stock/news/2232440/why-integer-itgr-is-a-top-value-stock-for-the-long-term?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_value_score-2232440
Feb 27, 2024 - Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
zc:375226197444117031
0
https://www.zacks.com/stock/news/2233479/vacasa-inc-vcsa-reports-q4-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2233479
Feb 28, 2024 - Vacasa, Inc. (VCSA) delivered earnings and revenue surprises of 48.97% and 0.80%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
zc:-4566181266615820595
0
https://www.zacks.com/stock/news/2233363/are-you-looking-for-a-top-momentum-pick-why-ralph-lauren-rl-is-a-great-choice?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_10-2233363
Feb 28, 2024 - Does Ralph Lauren (RL) have what it takes to be a top stock pick for momentum investors? Let's find out.
zc:-312819019457198
0
https://www.zacks.com/stock/news/2233474/petiq-petq-reports-q4-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2233474
Feb 28, 2024 - PetIQ (PETQ) delivered earnings and revenue surprises of 58.62% and 15.93%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
zc:-6210341816961897709
0
https://www.zacks.com/commentary/2232860/top-research-reports-for-nvidia-visa-amgen?cid=CS-ZC-FT-research_daily-2232860
Feb 28, 2024 - Today's Research Daily features new research reports on 16 major stocks, including NVIDIA Corporation (NVDA), Visa Inc. (V) and Amgen Inc. (AMGN).
zc:3063361431494597975
0
https://www.zacks.com/stock/news/2233478/u-s-physical-therapy-usph-tops-q4-earnings-and-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2233478
Feb 28, 2024 - U.S. Physical Therapy (USPH) delivered earnings and revenue surprises of 3.51% and 3.05%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
zc:-5098964770443612988
0
https://www.zacks.com/stock/news/2233403/marqeta-mq-reports-q4-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2233403
Feb 28, 2024 - Marqeta (MQ) delivered earnings and revenue surprises of 11.11% and 7.66%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
zc:-2830484856436627275
0
https://www.zacks.com/stock/news/2233288/inhibrx-inc-inbx-reports-q4-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2233288
Feb 28, 2024 - Inhibrx, Inc. (INBX) delivered earnings and revenue surprises of -61.68% and 1,534%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
zc:-3090902795360524255
0
https://www.zacks.com/stock/news/2233224/why-cheesecake-factory-cake-is-a-top-growth-stock-for-the-long-term?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_growth_score-2233224
Feb 28, 2024 - Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
zc:-4854790218953080452
0